Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

PLK1 is a binding partner and a negative regulator of FOXO3 tumor suppressor.

PLK1 is a binding partner and a negative regulator of FOXO3 tumor suppressor. Discoveries (Craiova). 2014 Apr-Jun; 2(2).

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.